Antinuclear antibodies (ANA) / screening

Antinuclear antibodies (ANA) and their role in the diagnosis and research of autoimmune diseases

Autoimmunology is a branch of medicine that studies disorders of the immune system when it attacks the body's own cells and tissues. This category of diseases is becoming increasingly common and important in the modern medical world. Antinuclear antibodies (ANA) play an important role in the diagnosis and study of autoimmune diseases.

Antinuclear antibodies (ANA) are antibodies directed against components of the cell nucleus, such as DNA and RNA. They may be present in the serum of a patient with autoimmune diseases such as systemic lupus erythematosus, rheumatoid arthritis, systemic scleroderma, and others.

ANA testing is an important step in determining the possible presence of an autoimmune disease. They can be detected using an immunofluorescence assay, where the patient's serum interacts with various components of the cell nucleus. The results of this assay are expressed as specific patterns that indicate the presence of antibodies to specific components of the nucleus.

However, it is important to understand that the presence of ANA in the blood is not sufficient grounds for diagnosing an autoimmune disease. These antibodies can also be found in healthy people, especially in women after the age of 65. ANA can also appear in other conditions not related to autoimmune diseases, such as infections.

To diagnose a specific autoimmune disease, doctors use other clinical and laboratory findings along with ANA results. For example, in systemic lupus erythematosus, antibodies to certain specific antigens, such as dsDNA or Sm antibodies, may be tested.

ANA tests also help doctors monitor the course of the disease and determine the effectiveness of treatment. An increase in ANA titer after previous normalization may indicate a relapse of the disease.

In general, antinuclear antibodies (ANA) are an important tool in the diagnosis and investigation of autoimmune diseases. Their presence may indicate the possibility of an autoimmune reaction in the patient's body, but other clinical and laboratory data must be taken into account for accurate diagnosis and treatment. It is important to work with a qualified rheumatologist or immunologist to determine the correct diagnosis and choose the optimal treatment for each patient.